CSI Market
Sign In | Register

Immuneering (IMRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access IMRX quarterly Balance Sheets →
This page allows investors to track Immuneering's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent128.65
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments128.00
Accounts receivable0.00
Other Current Assets44.19
Prepaid Expense And Other Assets Current3.41
Total Current Assets176.25
Equipment/Property/Plant Net0.94
Goodwill net6.69
Intangible Assets0.32
Long-term investments0.00
Other Assets, Noncurrent47.79
Debt Securities Available For Sale Excluding Accrued Interest Current44.19
Debt Securities Available For Sale Excluding Accrued Interest Noncurrent44.18
Operating Lease Right Of Use Asset3.32
Total Assets231.99
Liabilities
Accounts Payable, Current AC1.54
Accrued Liabilities, Current AC7.84
Other Liabilities, Current0.69
Total Current Liabilities10.07
Total Long-term Debt0.00
Other liabilities, Noncurrent3.43
DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent44.18
Operating Lease Liability Current0.40
Total Liabilities13.50
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock498.66
Retained Earnings / Accumulated Deficit-280.32
Other Equity0.08
Common Stockholder's Equity218.48
Total Stockholder's Equity218.48
Liabilities & Stockholder's Equity231.99
4 historic quarters locked

Sign in to unlock the full Immuneering balance sheet history.

Sign In Create Free Account

About Immuneering Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001790340-26-000042

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License